INRA-Université de Nantes, UMR 1280 PhAN, Institut des Maladies de l'Appareil Digestif (IMAD), Centre de Recherche en Nutrition Humaine Ouest (CRNHO), F-44093, Nantes, France.
INRA-Université de Nantes, UMR 1280 PhAN, Institut des Maladies de l'Appareil Digestif (IMAD), Centre de Recherche en Nutrition Humaine Ouest (CRNHO), F-44093, Nantes, France; Nutrition Support Team, University hospital Hôtel-Dieu, F-44093 Nantes, France.
J Nutr Biochem. 2018 May;55:104-112. doi: 10.1016/j.jnutbio.2017.12.007. Epub 2017 Dec 27.
Intrauterine growth restriction (IUGR) can affect the structure and function of the intestinal barrier and increase digestive disease risk in adulthood. Using the rat model of maternal dietary protein restriction (8% vs. 20%), we found that the colon of IUGR offspring displayed decreased mRNA expression of epithelial barrier proteins MUC2 and occludin during development. This was associated with increased mRNA expression of endoplasmic reticulum (ER) stress marker XBP1s and increased colonic permeability measured in Ussing chambers. We hypothesized that ER stress contributes to colonic barrier alterations and that perinatal supplementation of dams with ER stress modulators, phenylbutyrate and glutamine (PG) could prevent these defects in IUGR offspring. We first demonstrated that ER stress induction by tunicamycin or thapsigargin increased the permeability of rat colonic tissues mounted in Ussing chamber and that PG treatment prevented this effect. Therefore, we supplemented the diet of control and IUGR dams with PG during gestation and lactation. Real-time polymerase chain reaction and histological analysis of colons from 120-day-old offspring revealed that perinatal PG treatment partially prevented the increased expression of ER stress markers but reversed the reduction of crypt depth and goblet cell number in IUGR rats. In dextran sodium sulfate-induced injury and recovery experiments, the colon of IUGR rats without perinatal PG treatment showed higher XBP1s mRNA levels and histological scores of inflammation than IUGR rats with perinatal PG treatment. In conclusion, these data suggest that perinatal supplementation with PG could alleviate ER stress and prevent epithelial barrier dysfunction in IUGR offspring.
宫内生长受限(IUGR)可影响肠道屏障的结构和功能,并增加成年后患消化道疾病的风险。我们使用大鼠模型,对母体饮食蛋白质限制(8%对 20%)进行研究,发现 IUGR 后代的结肠在发育过程中,上皮屏障蛋白 MUC2 和闭合蛋白的 mRNA 表达减少。这与内质网(ER)应激标志物 XBP1s 的 mRNA 表达增加以及 Ussing 室测量的结肠通透性增加有关。我们假设 ER 应激导致结肠屏障改变,围产期母体 ER 应激调节剂苯丁酸钠和谷氨酰胺(PG)的补充可以预防 IUGR 后代的这些缺陷。我们首先证明,衣霉素或他普西坦诱导的 ER 应激增加了 Ussing 室中大鼠结肠组织的通透性,而 PG 处理可防止这种作用。因此,我们在妊娠和哺乳期期间,用 PG 补充对照和 IUGR 母鼠的饮食。120 日龄后代结肠的实时聚合酶链反应和组织学分析显示,围产期 PG 处理部分预防了 ER 应激标志物的增加,但逆转了 IUGR 大鼠隐窝深度和杯状细胞数量的减少。在葡聚糖硫酸钠诱导的损伤和恢复实验中,未经围产期 PG 处理的 IUGR 大鼠的结肠显示出更高的 XBP1s mRNA 水平和炎症组织学评分,高于经围产期 PG 处理的 IUGR 大鼠。总之,这些数据表明,围产期补充 PG 可以缓解 ER 应激并预防 IUGR 后代的上皮屏障功能障碍。